Tom Carmody

1.4k total citations · 1 hit paper
10 papers, 1.0k citations indexed

About

Tom Carmody is a scholar working on Psychiatry and Mental health, Pharmacology and Social Psychology. According to data from OpenAlex, Tom Carmody has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 2 papers in Social Psychology. Recurrent topics in Tom Carmody's work include Treatment of Major Depression (5 papers), Bipolar Disorder and Treatment (4 papers) and Schizophrenia research and treatment (4 papers). Tom Carmody is often cited by papers focused on Treatment of Major Depression (5 papers), Bipolar Disorder and Treatment (4 papers) and Schizophrenia research and treatment (4 papers). Tom Carmody collaborates with scholars based in United States and United Kingdom. Tom Carmody's co-authors include A. John Rush, Trisha Suppes, T. Michael Kashner, Kathy Shores‐Wilson, M. Lynn Crismon, Bradley Witte, Madhukar H. Trivedi, Melanie M. Biggs, Marcia G. Toprac and Ellen B. Dennehy and has published in prestigious journals such as Biological Psychiatry, Psychological Medicine and Schizophrenia Bulletin.

In The Last Decade

Tom Carmody

10 papers receiving 1.0k citations

Hit Papers

The Inventory of Depressive Symptomatology, Clinician Rat... 2004 2026 2011 2018 2004 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Carmody United States 6 411 400 389 355 146 10 1.0k
Jean Endicott United States 10 402 1.0× 309 0.8× 260 0.7× 331 0.9× 183 1.3× 12 1.1k
B A Raj United States 6 415 1.0× 468 1.2× 324 0.8× 548 1.5× 235 1.6× 9 1.4k
J Guelfi France 21 710 1.7× 394 1.0× 361 0.9× 675 1.9× 135 0.9× 62 1.6k
R. Ramana United Kingdom 12 592 1.4× 526 1.3× 636 1.6× 377 1.1× 262 1.8× 18 1.3k
M E Thase United States 14 592 1.4× 378 0.9× 614 1.6× 397 1.1× 181 1.2× 18 1.5k
Kay Roy Australia 17 366 0.9× 237 0.6× 328 0.8× 389 1.1× 161 1.1× 25 983
Deborah R. Schuller Canada 17 425 1.0× 584 1.5× 362 0.9× 751 2.1× 220 1.5× 20 1.5k
Laura Thomas United Kingdom 15 278 0.7× 298 0.7× 355 0.9× 227 0.6× 185 1.3× 24 1.0k
Kristina Fritz Australia 17 638 1.6× 202 0.5× 288 0.7× 281 0.8× 130 0.9× 34 1.2k
W.A. Nolen Netherlands 13 297 0.7× 233 0.6× 209 0.5× 207 0.6× 199 1.4× 36 851

Countries citing papers authored by Tom Carmody

Since Specialization
Citations

This map shows the geographic impact of Tom Carmody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Carmody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Carmody more than expected).

Fields of papers citing papers by Tom Carmody

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Carmody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Carmody. The network helps show where Tom Carmody may publish in the future.

Co-authorship network of co-authors of Tom Carmody

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Carmody. A scholar is included among the top collaborators of Tom Carmody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Carmody. Tom Carmody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vidot, Denise C., Chad D. Rethorst, Tom Carmody, et al.. (2019). Acute and long-term cannabis use among stimulant users: Results from CTN-0037 Stimulant Reduction Intervention using Dosed Exercise (STRIDE) Randomized Control Trial. Drug and Alcohol Dependence. 200. 139–144. 3 indexed citations
2.
Chartier, Karen G., et al.. (2015). Hispanic Subgroups, Acculturation, and Substance Abuse Treatment Outcomes. Journal of Substance Abuse Treatment. 59. 74–82. 13 indexed citations
4.
Trivedi, Madhukar H., A. John Rush, Hisham M. Ibrahim, et al.. (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychological Medicine. 34(1). 73–82. 802 indexed citations breakdown →
5.
Crismon, M. Lynn, A. John Rush, John A. Chiles, et al.. (2004). The Texas Medication Algorithm Project: Clinical Results for Schizophrenia. Schizophrenia Bulletin. 30(3). 627–647. 71 indexed citations
6.
Byerly, Matthew, et al.. (2003). An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction. Schizophrenia Research. 60(1). 276–276. 1 indexed citations
7.
Brown, E. Sherwood, et al.. (2001). Atypical Antipsychotics in Bipolar and Schizoaffective Disorders. Pharmacopsychiatry. 34(2). 80–81. 13 indexed citations
8.
Rush, A. John, Madhukar H. Trivedi, Sharyn R. Batey, et al.. (2000). Anxiolysis associated with antidepressant response to bupropion sustained release or sertraline. European Neuropsychopharmacology. 10. 236–236. 2 indexed citations
9.
Emslie, Graham J., A. John Rush, Warren A. Weinberg, et al.. (1998). Fluoxetine in child and adolescent depression: Acute and maintenance treatment. Depression and Anxiety. 7(1). 32–39. 127 indexed citations
10.
Suppes, Trisha, et al.. (1996). A one year randomized trial of clozapine vs. usual care in bipolar I patients. Biological Psychiatry. 39(7). 531–531. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026